119 related articles for article (PubMed ID: 552592)
1. Influence of hepatic insufficiency in pharmacokinetics of drugs: example for an anthranilic diuretic.
Dreux C; Passa P; Halter D
Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):289-96. PubMed ID: 552592
[TBL] [Abstract][Full Text] [Related]
2. Consequences of renal insufficiency on the hepatic clearance of some drugs.
Balant LP; Dayer P; Fabre J
Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
[TBL] [Abstract][Full Text] [Related]
3. Disease-induced modifications of drug pharmacokinetics.
Barre J; Houin G; Brunner F; Bree F; Tillement JP
Int J Clin Pharmacol Res; 1983; 3(4):215-26. PubMed ID: 6381335
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosis.
Traeger A; Häntze R; Penzlin M; Krombholz B; Reinhardt M; Keil E; Jorke D
Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):129-33. PubMed ID: 3997298
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of cimetidine on furosemide kinetics and dynamics in patients with hepatic cirrhosis.
Sanchis Closa A; Lambert C; du Souich P
Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):461-6. PubMed ID: 8225696
[TBL] [Abstract][Full Text] [Related]
6. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
Rector WG
Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
[TBL] [Abstract][Full Text] [Related]
7. Furosemide disposition in cirrhotic patients.
Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
[TBL] [Abstract][Full Text] [Related]
8. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
9. The influence of circadian rhythms on the kinetics of drugs in humans.
Baraldo M
Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):175-92. PubMed ID: 18248311
[TBL] [Abstract][Full Text] [Related]
10. [Basic mechanisms of chronopharmacology].
Labrecque G; Bélanger PM
Pathol Biol (Paris); 1987 Jun; 35(6):917-23. PubMed ID: 3306572
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and metabolism of theophylline in patients with liver diseases.
Staib AH; Schuppan D; Lissner R; Zilly W; von Bomhard G; Richter E
Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):500-2. PubMed ID: 7203726
[TBL] [Abstract][Full Text] [Related]
12. Kinetics and dynamics of triamterene at steady-state in patients with cirrhosis.
Dao MT; Villeneuve JP
Clin Invest Med; 1988 Feb; 11(1):6-9. PubMed ID: 3365882
[TBL] [Abstract][Full Text] [Related]
13. Effect of cimetidine on the absorption and efficacy of orally administered furosemide.
Rogers HJ; Morrison P; House FR; Bradbrook ID
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):8-11. PubMed ID: 7056605
[TBL] [Abstract][Full Text] [Related]
14. Furosemide disposition in normal and proteinuric rats: urinary drug-protein binding as a determinant of drug excretion.
Green TP; Mirkin BL
J Pharmacol Exp Ther; 1981 Jul; 218(1):122-7. PubMed ID: 7241373
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding model.
Stoeckel K; Koup JR
Am J Med; 1984 Oct; 77(4C):26-32. PubMed ID: 6093514
[TBL] [Abstract][Full Text] [Related]
16. Normal metabolism of morphine in cirrhosis.
Patwardhan RV; Johnson RF; Hoyumpa A; Sheehan JJ; Desmond PV; Wilkinson GR; Branch RA; Schenker S
Gastroenterology; 1981 Dec; 81(6):1006-11. PubMed ID: 7286578
[TBL] [Abstract][Full Text] [Related]
17. Furosemide kinetics and dynamics in patients with cirrhosis.
Villeneuve JP; Verbeeck RK; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1986 Jul; 40(1):14-20. PubMed ID: 3720175
[TBL] [Abstract][Full Text] [Related]
18. The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dog.
Data JL; Rane A; Gerkens J; Wilkinson GR; Nies AS; Branch RA
J Pharmacol Exp Ther; 1978 Aug; 206(2):431-8. PubMed ID: 682123
[TBL] [Abstract][Full Text] [Related]
19. Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide.
Keller E; Hoppe-Seyler G; Mumm R; Schollmeyer P
Eur J Clin Pharmacol; 1981; 20(1):27-33. PubMed ID: 7308269
[TBL] [Abstract][Full Text] [Related]
20. Regulation of urea synthesis by diet protein and carbohydrate in normal man and in patients with cirrhosis. Relationship to glucagon and insulin.
Hamberg O
Dan Med Bull; 1997 Jun; 44(3):225-41. PubMed ID: 9233544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
